Efficacy of thrombopoietin receptor agonists versus rituximab in non‐responsive immune thrombocytopenia—A single centre retrospective analysis
Sebastian M. Stolz,
Rahel Schwotzer,
Wiebke Rösler
et al.
Abstract:SummaryManagement of immune thrombocytopenia (ITP) beyond initial glucocorticoid therapy is challenging. In this retrospective single‐centre cohort study, we compared all ITP patients relapsed or non‐responsive to glucocorticoid therapy treated with either continuous TPO‐RAs (n = 35) or rituximab induction (n = 20) between 2015 and 2022. While both groups showed high initial complete response rates (CR, 68.6 vs. 80.0%, ns), the overall rate of progression to the next therapy was higher after time‐limited ritux… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.